The population studies showed that plasma CTGF was a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure and high levels of CTGF can predict future myocardial infarction (MI) and cardiovascular death in patients with type 2 diabetes (14, 19). The gene discussed is CCN2; the disease is type 2 diabetes mellitus.